NCT01284153

Brief Summary

This study has the purpose to investigate the benefit of treating breast cancer patients in prone position. This treatment is compared to the standard technique in our center (supine position with or without respiratory gating). The investigators want to compare the doses on the organs at risk (heart and lungs) in the different techniques.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

January 24, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 26, 2011

Completed
14.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2025

Completed
Last Updated

July 1, 2024

Status Verified

June 1, 2024

Enrollment Period

14.8 years

First QC Date

January 24, 2011

Last Update Submit

June 28, 2024

Conditions

Breast NeoplasmsRadiation

Keywords

respiratory gatingprone radiotherapybreast cancer

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who have an indication for radiotherapy of the breast and/or the lymph nodes.

You may qualify if:

  • indication for radiotherapy of the breast and /or lymph nodes

You may not qualify if:

  • none ( planning study)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Leuven Radiotherapy Department

Leuven, 3000, Belgium

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Caroline Sweldens, Doctor

    UZ Leuven

    STUDY DIRECTOR

Central Study Contacts

Caroline Sweldens, Doctor

CONTACT

003216347600caroline.sweldens@uzleuven.be

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 24, 2011

First Posted

January 26, 2011

Study Start

January 1, 2011

Primary Completion

October 1, 2025

Study Completion

October 1, 2025

Last Updated

July 1, 2024

Record last verified: 2024-06

Locations

BE(1)